HomeCompareFBHS vs MRK

FBHS vs MRK: Dividend Comparison 2026

FBHS yields 10.76% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.1K in total portfolio value· pulled ahead in Year 2
10 years
FBHS
FBHS
● Live price
10.76%
Share price
$61.90
Annual div
$6.66
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.6K
Annual income
$1.15
Full FBHS calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — FBHS vs MRK

📍 MRK pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFBHSMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FBHS + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FBHS pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FBHS
Annual income on $10K today (after 15% tax)
$914.54/yr
After 10yr DRIP, annual income (after tax)
$0.98/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,595.74/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FBHS + MRK for your $10,000?

FBHS: 50%MRK: 50%
100% MRK50/50100% FBHS
Portfolio after 10yr
$39.6K
Annual income
$5,057.47/yr
Blended yield
12.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

FBHS
Analyst Ratings
18
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$86.55
+39.8% upside vs current
Range: $48.00 — $125.00
Altman Z
2.9
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FBHS buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFBHSMRK
Forward yield10.76%2.81%
Annual dividend / share$6.66$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$21.6K$57.7K
Annual income after 10y$1.15$10,113.78
Total dividends collected$1.1K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy
Analyst price target$86.55$128.54

Year-by-year: FBHS vs MRK ($10,000, DRIP)

YearFBHS PortfolioFBHS Income/yrMRK PortfolioMRK Income/yrGap
1$11,238$537.96$11,213$373.04+$25.00FBHS
2← crossover$12,307$282.51$12,667$512.06$360.00MRK
3$13,313$144.57$14,439$708.14$1.1KMRK
4$14,318$73.08$16,640$988.16$2.3KMRK
5$15,357$36.73$19,432$1,394.07$4.1KMRK
6$16,451$18.41$23,057$1,992.90$6.6KMRK
7$17,611$9.21$27,889$2,894.79$10.3KMRK
8$18,849$4.61$34,518$4,286.29$15.7KMRK
9$20,170$2.31$43,912$6,494.35$23.7KMRK
10$21,584$1.15$57,714$10,113.78$36.1KMRK

FBHS vs MRK: Complete Analysis 2026

FBHSStock

Fortune Brands Home & Security, Inc. provides home and security products for residential home repair, remodeling, new construction, and security applications. It manufactures, assembles, and sells faucets, accessories, kitchen sinks, and waste disposals under the Moen, ROHL, Riobel, Victoria+Albert, Perrin & Rowe, and Shaws brands in the United States, China, Canada, Mexico, Southeast Asia, Europe, and South America directly through its own sales force, as well as through independent manufacturers' representatives to wholesalers, home centers, mass merchandisers, and industrial distributors. The company also offers fiberglass and steel entry door systems under the Therma-Tru brand; storm, screen, and security doors under the Larson brand; composite decking and railing under the Fiberon brand; and urethane millwork under the Fypon brand. In addition, it manufactures, sources, and distributes locks, safety and security devices, and electronic security products under the Master Lock and American Lock brands; and fire resistant safes, security containers, and commercial cabinets under the SentrySafe brand. It serves home centers, hardware and other retailers, millwork building products and wholesale distributors, specialty dealers, and remodeling and renovation markets, as well as locksmiths, industrial and institutional users, and original equipment manufacturers in the United States, Canada, Europe, Central America, Japan, and Australia. Further, it manufactures custom, semi-custom, and custom cabinetry, as well as vanities for the kitchen, bath, and other parts of the home directly to kitchen and bath dealers, home centers, wholesalers, and builders in North America under the AOK, Diamond Brands, Homecrest, Kitchen Craft, Omega, and EVE brands. The company was incorporated in 1988 and is headquartered in Deerfield, Illinois.

Full FBHS Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this FBHS vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FBHS vs SCHDFBHS vs JEPIFBHS vs OFBHS vs KOFBHS vs MAINFBHS vs JNJFBHS vs ABBVFBHS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.